Kezar Life Sciences (KZR) Competitors $4.09 +0.27 (+6.96%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KZR vs. COYA, IOBT, EQ, ADAG, BMEA, ANEB, MGNX, SAVA, TCRX, and ANROShould you be buying Kezar Life Sciences stock or one of its competitors? The main competitors of Kezar Life Sciences include Coya Therapeutics (COYA), IO Biotech (IOBT), Equillium (EQ), Adagene (ADAG), Biomea Fusion (BMEA), Anebulo Pharmaceuticals (ANEB), MacroGenics (MGNX), Cassava Sciences (SAVA), TScan Therapeutics (TCRX), and Alto Neuroscience (ANRO). These companies are all part of the "pharmaceutical products" industry. Kezar Life Sciences vs. Its Competitors Coya Therapeutics IO Biotech Equillium Adagene Biomea Fusion Anebulo Pharmaceuticals MacroGenics Cassava Sciences TScan Therapeutics Alto Neuroscience Coya Therapeutics (NASDAQ:COYA) and Kezar Life Sciences (NASDAQ:KZR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership, media sentiment and dividends. Which has more risk and volatility, COYA or KZR? Coya Therapeutics has a beta of 0.26, indicating that its share price is 74% less volatile than the S&P 500. Comparatively, Kezar Life Sciences has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500. Does the media favor COYA or KZR? In the previous week, Coya Therapeutics had 4 more articles in the media than Kezar Life Sciences. MarketBeat recorded 4 mentions for Coya Therapeutics and 0 mentions for Kezar Life Sciences. Coya Therapeutics' average media sentiment score of 0.38 beat Kezar Life Sciences' score of 0.00 indicating that Coya Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Coya Therapeutics Neutral Kezar Life Sciences Neutral Is COYA or KZR more profitable? Coya Therapeutics' return on equity of -61.05% beat Kezar Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Coya TherapeuticsN/A -61.05% -53.61% Kezar Life Sciences N/A -63.51%-52.13% Which has better valuation & earnings, COYA or KZR? Coya Therapeutics has higher earnings, but lower revenue than Kezar Life Sciences. Coya Therapeutics is trading at a lower price-to-earnings ratio than Kezar Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCoya Therapeutics$3.55M29.20-$14.88M-$1.24-5.00Kezar Life Sciences$7M4.30-$83.74M-$9.69-0.42 Do analysts recommend COYA or KZR? Coya Therapeutics currently has a consensus target price of $16.50, indicating a potential upside of 166.30%. Kezar Life Sciences has a consensus target price of $9.00, indicating a potential upside of 119.08%. Given Coya Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Coya Therapeutics is more favorable than Kezar Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Coya Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Kezar Life Sciences 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Do insiders & institutionals have more ownership in COYA or KZR? 39.8% of Coya Therapeutics shares are held by institutional investors. Comparatively, 67.9% of Kezar Life Sciences shares are held by institutional investors. 12.0% of Coya Therapeutics shares are held by insiders. Comparatively, 10.4% of Kezar Life Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryCoya Therapeutics beats Kezar Life Sciences on 10 of the 15 factors compared between the two stocks. Get Kezar Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KZR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KZR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KZR vs. The Competition Export to ExcelMetricKezar Life SciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$30.07M$3.16B$5.78B$9.92BDividend YieldN/A2.28%6.67%4.52%P/E Ratio-0.4221.1175.6726.67Price / Sales4.30463.83554.40206.13Price / CashN/A45.1137.1158.92Price / Book0.269.8611.446.09Net Income-$83.74M-$53.47M$3.28B$266.14M7 Day Performance4.00%2.79%0.78%0.22%1 Month Performance0.93%8.49%7.07%4.08%1 Year Performance-29.16%13.61%59.61%23.89% Kezar Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KZRKezar Life Sciences2.7776 of 5 stars$4.11+7.5%$9.00+119.1%-32.4%$30.07M$7M-0.4260COYACoya Therapeutics2.6379 of 5 stars$6.50-5.2%$16.50+153.8%+9.6%$114.73M$3.55M-5.246Analyst ForecastGap UpHigh Trading VolumeIOBTIO Biotech2.3274 of 5 stars$1.71-1.7%$8.67+406.8%+84.3%$114.63MN/A-1.0830Short Interest ↑EQEquillium0.4999 of 5 stars$1.90flat$1.00-47.4%+76.6%$113.06M$16.55M-3.3940News CoverageShort Interest ↑ADAGAdagene3.0499 of 5 stars$2.35-1.7%$7.00+197.9%-25.2%$112.59M$100K0.00260Short Interest ↓BMEABiomea Fusion3.4689 of 5 stars$1.81-1.1%$16.80+828.2%-76.1%$108.90MN/A-0.6050News CoverageANEBAnebulo Pharmaceuticals1.9721 of 5 stars$2.70+3.8%$5.50+103.7%+27.1%$106.82MN/A-10.384MGNXMacroGenics4.0631 of 5 stars$1.64-3.0%$3.60+119.5%-41.6%$106.82M$149.96M-2.88430Gap UpSAVACassava Sciences2.722 of 5 stars$2.16-1.8%$2.00-7.4%-92.8%$106.28MN/A-0.8530Positive NewsTCRXTScan Therapeutics2.7953 of 5 stars$1.90+1.6%$7.80+310.5%-66.2%$106.12M$2.82M-1.74100News CoveragePositive NewsANROAlto Neuroscience2.7223 of 5 stars$3.93+0.8%$8.50+116.3%-73.7%$105.60MN/A-1.64N/A Related Companies and Tools Related Companies COYA Competitors IOBT Competitors EQ Competitors ADAG Competitors BMEA Competitors ANEB Competitors MGNX Competitors SAVA Competitors TCRX Competitors ANRO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KZR) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kezar Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kezar Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KZR Stock Alerts